SOPHARMA AD: Invitation and materials for a General shareholders meeting

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No

/

2026

Date of issue:

2026-09-25

Short name of the issuer

SOPHARMA AD

Subject

Invitation and materials for a General shareholders meeting

Official market - legal basis

Art. 56 ust. 1 pkt 2 Ustawy o ofercie – informacje bieї№ce i okresowe

Unofficial market - legal basis

Contents of the report:

Publication of materials

for holding an Extraordinary General Meeting of Shareholders of “Sopharma” AD, scheduled for October 30, 2026 and in the absence of a quorum on this date – for November 20, 2026

Sofia, Bulgaria, September 25, 2026 - According to the requirements of Art. 100t of the Law on Public Offering of Securities the Board of directors of “Sopharma” AD (SFA: “BSE“ AD, SPH: Warsaw Stock Exchange) presents the following materials on the agenda of EGM convened for October 30, 2026 and in the absence of a quorum on this date – for November 20, 2026, to the attention of shareholders, which will be available on the website of Extri News (www.x3news.com), in the FSC system, on the Company's website https://www.sopharmagroup.com/bg/investitori/korporativni-sabitia/obshto-sabranie-na-aktsionerite and on the website www.investor.bg, as well as in hard copy at the address of the Company:

1. Minutes of a meeting of the Board of Directors for convening an Extraordinary Meeting of Shareholders of “Sopharma” AD;

2. Invitation to convene the Extraordinary General Meeting of Shareholders (EGM) of “Sopharma” AD;

3. Power of attorney – an example for representing a shareholder at the EGM;

4. Declaration for voting by correspondence – an example for the EGM;

5. For item 1 of the agenda: Approval of the 6-month financial report for the first half of 2026– is already available on the website of Extri News (www.x3news.bg), in the FSC system, on the company's website and on the website www.investor.bg;

6. For item 2 of the agenda: Approval of a decision under Article 30, paragraphs 5-7 of the Company's Articles of Association for the distribution of profit and payment of an interim dividend based on the adopted 6-month financial report;

7. For item 3 of the agenda: Election of a registered auditor to perform a mandatory assurance engagement regarding the sustainability of the consolidated sustainability report of “Sopharma” AD for 2026, if applicable.

Annexes

File

Description

SFA_286_EGM_30102026.rar

Invitation and materials for a General shareholders meeting

Legal framework

Type of information

RegulatoryData

Collection Body

PLKNF

Unique data record identifier

Type of submission

New (to be used for new information)

Voluntary information flag

Date or period covered [Date or beginning of the period to which the information relates]

2026-10-30

Date or period covered [Date or end of the period to which the information relates]

2026-10-30

Personal data flag

Macierzyste państwo członkowskie, w stosownych przypadkach

PL

DocumentReference

Język, w którym przekazano informacje

Oryginał (ORIG) czy tłumaczenie (TRAN)

Numer referencyjny pliku danych

PL

ORIG

SubmittingEntity

Submitting entity LEI

or

Submitting entity name - natural person

097900BGGW0000048796

RelatedEntity/LegalPerson

Entity LEI

Size of the entity

Industry sector(s)

097900BGGW0000048796

Large undertaking

(acc. NACE): C

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD

Farmaceutyczny (far)

(short name of the issuer)

(sector according to clasification

of the WSE in Warsow)

1220

Sofia

(post code)

(city)

IlienskoShosse

(street)

(number)

+359 2 813 42 00

+359 2 936 02 86

(phone number)

(fax)

(e-mail)

(web site)

nd

(NIP)

(REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY

2026-09-25

Ognian Ivanov Donev

Executive Director